XML 60 R54.htm IDEA: XBRL DOCUMENT
v3.24.3

Balance Sheet Components (Additional Information) (Details) - La Jolla Pharmaceutical Company - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended |
--- | --- | --- | ---
Sep. 30, 2024 | Sep. 30, 2023 | Sep. 30, 2024 | Sep. 30, 2023 | Dec. 31, 2023
Inventory [Line Items] |  |  |  |  |
Net fair value adjustment of inventory from acquisition | $ 10.9 |  | $ 10.9 |  | $ 23.0
Amortization of fair value adjustments of Cost of products sold | $ 1.8 | $ 5.4 | $ 12.1 | $ 19.2 |

X
- Definition Amortization of fair value adjustments of cost of products sold. + References No definition available. + Details
Name: | inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold
Namespace Prefix: | inva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Value of net fair value adjustment of inventory resulting from the acquisition. + References No definition available. + Details
Name: | inva_FairValueAdjustmentsOfInventoryFromAcquistion
Namespace Prefix: | inva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_InventoryLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_LaJollaPharmaceuticalCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |